Scleroderma Diagnostics & Therapeutics Market - Forecast 2022-2027
Scleroderma Diagnostics & Therapeutics Market Size is estimated to reach $3.8 billion by 2027 and it is poised to grow at a CAGR of 10.2% over the forecast period of 2022-2027. Scleroderma is a long-lasting disease that affects skin, connective tissue and internal organs. It occurs when the body produces an excessive amount of the protein collagen . Internal organs like the blood vessels, heart, lungs, stomach and kidneys may sustain an injury with this disease. Scleroderma is most prevalent in women than in males. Scleroderma comes in a variety of forms with varying degrees of severity. While some varieties can result in serious and life-threatening issues, others are rather moderate and may eventually improve on their own. As per the National Health Service of the United Kingdom, Scleroderma is categorized mainly into two types, localized scleroderma and systemic sclerosis. Scleroderma is diagnosed by using antibodies tests/blood tes...